Centogene N.V. logo

Centogene N.V.

NASDAQ:CNTG

Overview | Financials
Company Name Centogene N.V.
Symbol CNTG
Currency USD
Price 0.325
Market Cap 9,425,033
Dividend Yield 0%
52-week-range 0.14 - 1.53
Industry Diagnostics & Research
Sector Healthcare
CEO Ms. Kim Stratton
Website https://www.centogene.com

An error occurred while fetching data.

About Centogene N.V.

Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare disease platform, a data and biological repository,

Related Stocks

Eyenovia, Inc. logo

Eyenovia, Inc.

EYEN

0.537 USD

Galectin Therapeutics Inc. logo

Galectin Therapeutics Inc.

GALT

2.87 USD

Augmedix, Inc. logo

Augmedix, Inc.

AUGX

2.33 USD

Viracta Therapeutics, Inc. logo

Viracta Therapeutics, Inc.

VIRX

0.251 USD

Journey Medical Corporation logo

Journey Medical Corporation

DERM

5.16 USD

BriaCell Therapeutics Corp. logo

BriaCell Therapeutics Corp.

BCTX

0.561 USD

Minerva Surgical, Inc. logo

Minerva Surgical, Inc.

UTRS

0.012 USD

HCW Biologics Inc. logo

HCW Biologics Inc.

HCWB

0.61 USD

Financials

Numbers are in millions USD

Numbers are in millions USD